Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy
The endocannabinoid system plays an essential role in the regulation of analgesia and human immunity, and Cannabinoid Receptor 2 (CB2) has been proved to be an ideal target for the treatment of liver diseases and some cancers. In this study, we identified CB2 antagonists using a three-step “deep lea...
Enregistré dans:
Auteurs principaux: | Mukuo Wang, Shujing Hou, Ye Liu, Dongmei Li, Jianping Lin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5d2110cbb9644b1e972d0bfd4cd9f7ab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
par: Jiang Lili, et autres
Publié: (2021) -
Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations
par: Ajay Pal, et autres
Publié: (2021) -
<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
par: Mohamed S. Alesawy, et autres
Publié: (2021) -
Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
par: Bhargav Shreevatsa, et autres
Publié: (2021) -
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
par: Parthasaradhireddy Tanguturi, et autres
Publié: (2021)